Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Girdle muscular dystrophy. NGS panel of 39 genes. Genologica Medica Spain | 84 | 39 |
|
Skeletal diseases. NGS panel of 169 genes. Genologica Medica Spain | 373 | 169 |
|
Neuromuscular Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 138 | 62 |
|
Spinocerebellar ataxia, autosomal recessive: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 23 | 23 |
|
Fulgent Genetics United States | 186 | 61 |
|
Fulgent Genetics United States | 133 | 56 |
|
Autosomal Recessive Cerebellar Ataxia Type 1 (SYNE1 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 533 | 149 |
|
Limb-Girdle Muscular Dystrophy Asper Biogene Asper Biogene LLC Estonia | 87 | 39 |
|
SYNE1-Related Autosomal Recessive Cerebellar Ataxia: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Ataxia Related Disorders , Panel Massive Sequencing (NGS) 35 Genes Reference Laboratory Genetics Spain | 37 | 34 |
|
CEREBELLAR ATAXIA TYPE 8 (AUTOSOMAL RECESSIVE) Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Neuromuscular Disorders NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 233 | 144 |
|
Autosomal Recessive Spinocerebellar Ataxia Type 8 (SCAR8) , Sequencing SYNE1 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Ataxia, Comprehensive Evaluation Athena Diagnostics United States | 44 | 42 |
|
Ataxia, Complete Recessive Evaluation Athena Diagnostics United States | 21 | 18 |
|
Ataxia, Supplemental Recessive Evaluation Athena Diagnostics United States | 20 | 17 |
|
Asper Biogene Asper Biogene LLC Estonia | 180 | 139 |
|
Spinocerebellar ataxia, autosomal recessive 8 Bioarray Spain | 1 | 1 |
|
Ataxia and differential diagnoses Panel CeGaT GmbH Germany | 172 | 204 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.